BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31152257)

  • 1. sICAM-1 as potential additional parameter in the discrimination of the Sjögren syndrome and non-autoimmune sicca syndrome: a pilot study.
    Zinkevičienė A; Dumalakienė I; Mieliauskaitė D; Vilienė R; Narkevičiūtė I; Girkontaitė I
    Clin Rheumatol; 2019 Oct; 38(10):2803-2809. PubMed ID: 31152257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ICAM-1, VCAM-1 and E-selectin levels in patients with primary and secondary Sjögren's syndrome.
    Błochowiak KJ; Olewicz-Gawlik A; Trzybulska D; Nowak-Gabryel M; Kocięcki J; Witmanowski H; Sokalski J
    Adv Clin Exp Med; 2017 Aug; 26(5):835-842. PubMed ID: 29068581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
    Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
    Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Sjogren's Syndrome in 83 Patients With Rheumatoid Arthritis.
    Hajiabbasi A; Shenavar Masooleh I; Alizadeh Y; Banikarimi AS; Ghavidel Parsa P
    Acta Med Iran; 2016 Jul; 54(7):448-53. PubMed ID: 27424016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination between Sjögren's and non-Sjögren's sicca syndrome by sialoscintigraphy and antibodies against alpha-fodrin and Ro/La autoantigens.
    Chen KS; Jiang MC; Li CJ; Liu OK; Tsai CS
    J Int Med Res; 2009; 37(4):1088-96. PubMed ID: 19761691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and laboratory evaluation of sicca complaints: distinctive aspects of primary, secondary and non-Sjogren syndrome.
    de Oliveira FR; Motta ACF; Módulo CM; Garcia DM; Chiorini JA; Louzada-Junior P; Rocha EM
    Adv Rheumatol; 2022 Jul; 62(1):23. PubMed ID: 35778768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
    Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
    Front Immunol; 2021; 12():673658. PubMed ID: 34012457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of quantitative immunohistology in labial salivary glands for diagnosing Sjogren's syndrome.
    van Woerkom JM; Kruize AA; Barendregt PJ; Kater L; Hené R; Bootsma H; Custers RJ; Jacobs JW; Bijlsma JW
    Rheumatology (Oxford); 2006 Apr; 45(4):470-7. PubMed ID: 16287920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary cytokine profiles in primary Sjögren's syndrome differ from those in non-Sjögren sicca in terms of TNF-α levels and Th-1/Th-2 ratios.
    Kang EH; Lee YJ; Hyon JY; Yun PY; Song YW
    Clin Exp Rheumatol; 2011; 29(6):970-6. PubMed ID: 22132900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
    Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum soluble adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) and neopterin in patients with Sjögren's syndrome.
    Andrýs C; Krejsek J; Slezák R; Drahosová M; Kopecký O
    Acta Medica (Hradec Kralove); 1999; 42(3):97-101. PubMed ID: 10677896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.
    Mandal SK; Sandhya P; Kabeerdoss J; Ramya J; Mahasampath G; Danda D
    Rheumatol Int; 2018 May; 38(5):831-836. PubMed ID: 29541901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome.
    Tashbayev B; Rusthen S; Young A; Herlofson BB; Hove LH; Singh PB; Rykke M; Aqrawi LA; Chen X; Utheim ØA; Utheim TP; Palm Ø; Jensen JL
    Sci Rep; 2017 Sep; 7(1):10761. PubMed ID: 28883442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
    Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.
    van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal Fatty Acid-Binding Protein: A Novel Marker in the Diagnosis of Dry Eye Disease in Sjögren Syndrome.
    Shinzawa M; Dogru M; Den S; Ichijima T; Higa K; Kojima T; Seta N; Nomura T; Tsubota K; Shimazaki J
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of serum soluble intercellular adhesion molecule-1 (sICAM-1) and beta-2-microglobulin in Sjögren's syndrome.
    Krejsek J; Slezák R; Kopecky O; Derner V; Andrys C
    Clin Rheumatol; 1997 Mar; 16(2):149-53. PubMed ID: 9093796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
    Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
    Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.